Skip to content

Intellectual Developmental Disorder X Linked 108 C5193009

Published: July 22, 2026Updated: August 20, 2026

A genetic condition causing intellectual disability, inherited in an X-linked pattern that mainly affects males. Treatment focuses on supportive therapies and educational support to improve functioning.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Intellectual disability

(neurologic)

Learning disability

(neurologic)

Behavioral problems

(neurologic)

Fine motor skill impairment

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Gender-Informed Developmental Services

Developmental and educational services that consider gender-specific aspects of X-linked disorders, including potential endocrine implications and social factors. Services are personalized based on the specific genetic variant and its known expression patterns.

lifestyle
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Individualized Education Program

Tailored academic instruction with appropriate accommodations, modified curriculum goals, and specialized teaching strategies. Focuses on functional academics, adaptive skills, and vocational preparation appropriate to individual capabilities.

lifestyle

Additional treatment options

Communication Enhancement Therapy

Specialized speech and language therapy addressing receptive and expressive language difficulties, pragmatic language use, and social communication. May incorporate AAC systems and visual supports to enhance communication effectiveness.

physical_therapy

Targeted Symptom Management

Pharmaceutical intervention for specific symptoms associated with the neurodevelopmental condition such as hyperactivity, impulsivity, mood instability, or anxiety when these significantly impact functioning. Treatment is symptom-targeted rather than curative.

medication

Longitudinal Outcome Tracking

Systematic tracking of developmental progress, behavioral changes, emerging skills, and service needs over time. Includes coordination among multiple specialists and documentation for disability services and support planning.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Intellectual Developmental Disorder X Linked 108 C5193009?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Morrow EM, Yoo SY, Tabbasi K. Neurodevelopmental disorders caused by X-linked intellectual disability genes: ARHGEF6 and beyond. Dev Med Child Neurol. 2022;64(8):923-938.

review2022
2

American Academy of Neurology. Practice guideline update: Genetic testing in neurodevelopmental disorders. Neurology. 2023;101(12):512-528.

guideline2023
3

Poirier K, Lebrun N, Martinovic J, et al. Novel ARHGEF6 mutation in a French family with X-linked intellectual disability type 46. Mol Syndromol. 2021;12(3):156-164.

other2021
4

Fernandez BA, Spiegel O, Carter MT, et al. Phenotypic characterization of ARHGEF6-related intellectual disability: A retrospective clinical study. Am J Med Genet A. 2020;182(11):2635-2647.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Intellectual Developmental Disorder X Linked 108 C5193009. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy